Penumbra Inc Stock
Pros and Cons of Penumbra Inc in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Penumbra Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Penumbra Inc | 0.600% | -0.209% | -0.898% | 16.484% | 7.695% | 12.070% | 25.833% |
| Bio-Rad Labs Inc. A | 1.520% | 3.417% | 3.417% | 4.980% | -8.453% | -45.448% | -51.420% |
| Neogen Corp. | 1.920% | 3.871% | -16.146% | 0.000% | 30.894% | - | - |
| CONMED Corp. | -0.650% | -7.006% | -24.742% | -45.926% | -16.571% | -68.936% | -73.455% |
News
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity
Medical device manufacturer Boston Scientific Corp. (NYSE: BSX) is seemingly off to a tough start to the year, as shares have plunged by 26% year-to-date (YTD) and by almost a third in the last
